Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment-Reference-Cited by-同舟云学术

Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment

Published:2013-08 Issue:6 Volume:1 Page:462-470
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Friedrich Sven O,Rachow Andrea,Saathoff Elmar,Singh Kasha,Mangu Chacha D,Dawson Rodney,Phillips Patrick PJ,Venter Amour,Bateson Anna,Boehme Catharina C,Heinrich Norbert,Hunt Robert D,Boeree Martin J,Zumla Alimuddin,McHugh Timothy D,Gillespie Stephen H,Diacon Andreas H,Hoelscher Michael

Funder

European and Developing Countries Clinical Trials Partnership

Global Alliance for TB Drug Development, Bill & Melinda Gates Foundation, UK Medical Research Council, and German Ministry of Science and Technology

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference34 articles.

1. Scaling up interventions to achieve global tuberculosis control: progress and new developments;Raviglione;Lancet,2012

2. Advancing the development of tuberculosis therapy;Zumla;Nat Rev Drug Discov,2012

3. Innovative trial designs are practical solutions for improving the treatment of tuberculosis;Phillips;J Infect Dis,2012

4. Predicting the outcome of therapy for pulmonary tuberculosis;Wallis;Am J Respir Crit Care Med,2000

5. Quantitative studies of mycobacterial populations in sputum and saliva;Yeager;Am Rev Respir Dis,1967

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tuberculosis Diagnosis and Detection of Drug Resistance: A Comprehensive Updated Review;Journal of Pure and Applied Microbiology;2023-12-01

2. Localization and phenotyping of tuberculosis bacteria using a combination of deep learning and SVMs;Computers in Biology and Medicine;2023-12

3. A Systematic Review of Potential Biomarkers for Bacterial Burden and Treatment Efficacy Assessment in Tuberculosis Platform-Based Clinical Trials;The Journal of Infectious Diseases;2023-11-13

4. New Insights into Biomarkers for Evaluating Therapy Efficacy in Pulmonary Tuberculosis: A Narrative Review;Infectious Diseases and Therapy;2023-11-08

5. MicroRNA hsa-miR-320a-3p and Its Targeted mRNA FKBP5 Were Differentially Expressed in Patients with HIV/TB Co-Infection;ACS Infectious Diseases;2023-08-25